# EDGAR Filing Document

**Accession Number:** 0001613103
**File Stem:** 0001708062-26-000002
**Filing Date:** 2026-2
**Character Count:** 7352
**Document Hash:** 0719be6f08f97fab3622ad76da23dcd2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001708062-26-000002.hdr.sgml**: 20260226

**ACCESSION NUMBER**: 0001708062-26-000002

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260219

**FILED AS OF DATE**: 20260226

**DATE AS OF CHANGE**: 20260226

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** KIIL HARRY SKIP
- **CENTRAL INDEX KEY:** 0001708062

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36820
- **FILM NUMBER:** 26690984

**MAIL ADDRESS:**
- **STREET 1:** 7475 LUSK BLVD.
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Medtronic plc
- **CENTRAL INDEX KEY:** 0001613103
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **FISCAL YEAR END:** 0424

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** BUILDING TWO PARKMORE BUSINESS PARK WEST
- **CITY:** GALWAY
- **PROVINCE COUNTRY:** L2
- **ZIP:** H91 4K49
- **BUSINESS PHONE:** 01135314381700

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** BUILDING TWO PARKMORE BUSINESS PARK WEST
- **CITY:** GALWAY
- **PROVINCE COUNTRY:** L2
- **ZIP:** H91 4K49

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Medtronic Ltd
- **DATE OF NAME CHANGE:** 20150112

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Medtronic Holdings Ltd
- **DATE OF NAME CHANGE:** 20140711

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Kalani I Ltd
- **DATE OF NAME CHANGE:** 20140709

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>KIIL HARRY SKIP<br><sub>(Last) (First) (Middle)</sub><br>710 MEDTRONIC PARKWAY<br><sub>(Street)</sub><br>MINNEAPOLIS, MN 55432<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-02-19 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_EVP & President Cardiovascular_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Medtronic plc [ MDT ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Ordinary Shares | 2026-02-19 |  | M |  | 30568 | A | $93.08 | 64984<sup>(1)</sup> | D |  |
| Ordinary Shares | 2026-02-19 |  | M |  | 19923 | A | $87.76 | 84907 | D |  |
| Ordinary Shares | 2026-02-19 |  | M |  | 385 | A | $80 | 85292 | D |  |
| Ordinary Shares | 2026-02-19 |  | S |  | 1648 | D | $97.86 | 83644 | D |  |
| Ordinary Shares | 2026-02-19 |  | S |  | 30568 | D | 97.6634<sup>(2)</sup> | 53076 | D |  |
| Ordinary Shares | 2026-02-19 |  | S |  | 19255 | D | $97.77 | 33821 | D |  |
| Ordinary Shares | 2026-02-19 |  | S |  | 668 | D | $97.825 | 33153 | D |  |
| Ordinary Shares | 2026-02-19 |  | S |  | 385 | D | $97.82 | 32768 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Option (Right to Buy) | $93.08 | 2026-02-19 |  | M |  |  | 30568 | 2023-08-01 | 2032-08-01 | Ordinary Shares | 30568 | $0 | 11606 | D |  |
| Stock Option (Right to Buy) | $87.76 | 2026-02-19 |  | M |  |  | 19923 | 2024-07-31 | 2033-07-31 | Ordinary Shares | 19923 | $0 | 18926 | D |  |
| Stock Option (Right to Buy) | $80 | 2026-02-19 |  | M |  |  | 385 | 2025-07-29 | 2034-07-29 | Ordinary Shares | 385 | $0 | 1155 | D |  |

---

### Footnotes:

(1) Includes 239 shares acquired through dividend reinvestment since the last report filed by the reporting person.

(2) The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $97.60 to $97.775. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.

**Signature:** /s/ Patricia Walesiewicz, attorney-in-fact  
**Date:** 2026-02-26

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**